| Mrs Jessica Lynn Speir, NP | |
|
3124 S 19th St Ste 320, Tacoma, WA 98405-2433 | |
| (253) 301-5100 | |
| (253) 301-5101 |
| Full Name | Mrs Jessica Lynn Speir |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 19 Years |
| Location | 3124 S 19th St Ste 320, Tacoma, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225241334 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 0024166665 (Virginia) | Secondary |
| 363LA2200X | Nurse Practitioner - Adult Health | AP60261324 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tacoma General Allenmore Hospital | Tacoma, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Multicare Health System | 7719899897 | 1704 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.
People with rheumatic diseases don't take their medication on a regular basis, and this leads to poor outcomes in their disease treatment, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.
The combination of three complementary measures to eradicate tiger mosquitos - avoid having stagnant water, using insecticides to eliminate larvae and adults, and removing rubbish - reduces more than half the number of tiger mosquitos, according to a research coordinated by researchers at Universitat Autonoma de Barcelona.
When older adults suffer a traumatic brain injury (TBI), they may benefit from aggressive treatment and rehabilitation, but the lack of evidence-based, geriatric-specific TBI guidelines presents barriers to optimal care.
Tranzyme Pharma today announced that Philippa Charlton, MD, Tranzyme's Medical Director, and her colleagues G. Bochicchio, J.C. Pezullo, G. Kosutic, and A. Senagore, will present a poster entitled "The Prokinetic Agent TZP-101 (a Ghrelin Agonist) Accelerates GI Recovery in Partial Colectomy Patients Independently of Total Opioid Use and Type of Surgery" at the upcoming 2010 Annual Scientific Meeting of the American Society of Colon and Rectal Surgeons (ASCRS; Minneapolis, May 15-19).
› Verified 6 days ago
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.
People with rheumatic diseases don't take their medication on a regular basis, and this leads to poor outcomes in their disease treatment, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.
The combination of three complementary measures to eradicate tiger mosquitos - avoid having stagnant water, using insecticides to eliminate larvae and adults, and removing rubbish - reduces more than half the number of tiger mosquitos, according to a research coordinated by researchers at Universitat Autonoma de Barcelona.
When older adults suffer a traumatic brain injury (TBI), they may benefit from aggressive treatment and rehabilitation, but the lack of evidence-based, geriatric-specific TBI guidelines presents barriers to optimal care.
Tranzyme Pharma today announced that Philippa Charlton, MD, Tranzyme's Medical Director, and her colleagues G. Bochicchio, J.C. Pezullo, G. Kosutic, and A. Senagore, will present a poster entitled "The Prokinetic Agent TZP-101 (a Ghrelin Agonist) Accelerates GI Recovery in Partial Colectomy Patients Independently of Total Opioid Use and Type of Surgery" at the upcoming 2010 Annual Scientific Meeting of the American Society of Colon and Rectal Surgeons (ASCRS; Minneapolis, May 15-19).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jessica Lynn Speir, NP 3124 S 19th St Ste 320, Tacoma, WA 98405-2433 Ph: (253) 301-5100 | Mrs Jessica Lynn Speir, NP 3124 S 19th St Ste 320, Tacoma, WA 98405-2433 Ph: (253) 301-5100 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.
People with rheumatic diseases don't take their medication on a regular basis, and this leads to poor outcomes in their disease treatment, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.
The combination of three complementary measures to eradicate tiger mosquitos - avoid having stagnant water, using insecticides to eliminate larvae and adults, and removing rubbish - reduces more than half the number of tiger mosquitos, according to a research coordinated by researchers at Universitat Autonoma de Barcelona.
When older adults suffer a traumatic brain injury (TBI), they may benefit from aggressive treatment and rehabilitation, but the lack of evidence-based, geriatric-specific TBI guidelines presents barriers to optimal care.
Tranzyme Pharma today announced that Philippa Charlton, MD, Tranzyme's Medical Director, and her colleagues G. Bochicchio, J.C. Pezullo, G. Kosutic, and A. Senagore, will present a poster entitled "The Prokinetic Agent TZP-101 (a Ghrelin Agonist) Accelerates GI Recovery in Partial Colectomy Patients Independently of Total Opioid Use and Type of Surgery" at the upcoming 2010 Annual Scientific Meeting of the American Society of Colon and Rectal Surgeons (ASCRS; Minneapolis, May 15-19).
› Verified 6 days ago
Salome Odja Dockendorf, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1201 Pacific Ave Ste 19501201, Tacoma, WA 98402 Phone: 812-870-6728 | |
Barbara L Kapuscinski, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-2751 | |
Ms. Christine J. Larsen, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3580 Pacific Ave, Tacoma, WA 98418 Phone: 253-798-4500 Fax: 253-798-4493 | |
Rick Hahn, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
Mrs. Kimberley Anne Burns, APRN,BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1617 S J St, Tacoma, WA 98405 Phone: 253-274-7504 | |
Randi Marie Berg, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9040 Reid St, Tacoma, WA 98431 Phone: 253-968-2315 | |
Marlene I Bridgforth, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1901 S Cedar St, #301 Cardiac Study Center Inc Ps, Tacoma, WA 98405 Phone: 253-572-7320 Fax: 253-627-3191 |